In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Elanco Animal Health Inc (NYSE: ELAN) closed at $11.51 down -1.79% from its previous closing price of $11.72. In other words, the price has decreased by -$1.79 from its previous closing price. On the day, 5.66 million shares were traded. ELAN stock price reached its highest trading level at $11.73 during the session, while it also had its lowest trading level at $11.39.
Ratios:
For a deeper understanding of Elanco Animal Health Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.61 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.97. For the most recent quarter (mrq), Quick Ratio is recorded 1.31 and its Current Ratio is at 2.55. In the meantime, Its Debt-to-Equity ratio is 0.67 whereas as Long-Term Debt/Eq ratio is at 0.66.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on December 09, 2024, initiated with a Buy rating and assigned the stock a target price of $18.
On December 02, 2024, Leerink Partners started tracking the stock assigning a Market Perform rating and target price of $14.
Morgan Stanley Downgraded its Overweight to Equal-Weight on September 19, 2024, whereas the target price for the stock was revised from $17 to $15.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 22 ’24 when Harrington Michael J bought 3,500 shares for $14.85 per share. The transaction valued at 51,974 led to the insider holds 81,094 shares of the business.
Simmons Jeffrey N bought 100,000 shares of ELAN for $1,300,610 on Aug 12 ’24. The PRESIDENT, CEO AND DIRECTOR now owns 145,000 shares after completing the transaction at $13.01 per share. On May 21 ’24, another insider, DOYLE WILLIAM F, who serves as the Director of the company, bought 15,000 shares for $16.98 each. As a result, the insider paid 254,700 and bolstered with 76,330 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELAN now has a Market Capitalization of 5690002944 and an Enterprise Value of 9557001216. As of this moment, Elanco’s Price-to-Earnings (P/E) ratio for their current fiscal year is 28.17, and their Forward P/E ratio for the next fiscal year is 12.85. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.29. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.28 while its Price-to-Book (P/B) ratio in mrq is 0.87. Its current Enterprise Value per Revenue stands at 2.146 whereas that against EBITDA is 10.922.
Stock Price History:
The Beta on a monthly basis for ELAN is 1.44, which has changed by -0.25728768 over the last 52 weeks, in comparison to a change of 0.2000997 over the same period for the S&P500. Over the past 52 weeks, ELAN has reached a high of $18.80, while it has fallen to a 52-week low of $11.11. The 50-Day Moving Average of the stock is -6.02%, while the 200-Day Moving Average is calculated to be -17.93%.
Shares Statistics:
For the past three months, ELAN has traded an average of 4.64M shares per day and 5047560 over the past ten days. A total of 494.33M shares are outstanding, with a floating share count of 487.02M. Insiders hold about 1.48% of the company’s shares, while institutions hold 98.51% stake in the company. Shares short for ELAN as of 1736899200 were 16644112 with a Short Ratio of 3.59, compared to 1734048000 on 15625983. Therefore, it implies a Short% of Shares Outstanding of 16644112 and a Short% of Float of 5.4.
